Thomas C Freyman is Executive Vice President of ABBOTT LABORATORIES. Currently has a direct ownership of 395,819 shares of ABT, which is worth approximately $45.4 Million. The most recent transaction as insider was on Jul 29, 2016, when has been sold 42,863 shares (Common shares without par value) at a price of $44.45 per share, resulting in proceeds of $1,905,260. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 396K
0% 3M change
0% 12M change
Total Value Held $45.4 Million

THOMAS C FREYMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 29 2016
SELL
Payment of exercise price or tax liability
$1,905,260 $44.45 p/Share
42,863 Reduced 9.77%
395,819 Common shares without ...
Jul 29 2016
BUY
Exercise of conversion of derivative security
$1,414,000 $25.25 p/Share
56,000 Added 11.32%
438,682 Common shares without ...
Feb 29 2016
SELL
Payment of exercise price or tax liability
$786,764 $39.52 p/Share
19,908 Reduced 4.94%
382,682 Common shares without ...
Feb 19 2016
BUY
Grant, award, or other acquisition
-
55,338 Added 12.08%
402,590 Common shares without ...

Also insider at

ABBV
AbbVie Inc. Healthcare
TEN
TENNECO INC Consumer Cyclical
HNGR
HANGER, INC. Healthcare
TCF

Thomas C Freyman

Executive Vice President
North Chicago, IL

Track Institutional and Insider Activities on ABT

Follow ABBOTT LABORATORIES and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ABT shares.

Notify only if

Insider Trading

Get notified when an Abbott Laboratories insider buys or sells ABT shares.

Notify only if

News

Receive news related to ABBOTT LABORATORIES

Track Activities on ABT